Altered umbilical cord adipokine profile associated with maternal obesity: an exploratory cohort study
- 1Department of Obstetrics and Gynecology, Faculty of Medicine, Balikesir University
- 2Department of Pediatrics, Faculty of Medicine, Balikesir University
- 3Department of Medical Biochemistry, Faculty of Medicine, Balikesir University
Abstract
Background: Maternal obesity is associated with adverse pregnancy outcomes and may influence fetal metabolic programming through alterations in the intrauterine environment. While leptin has been extensively investigated in pregnancies complicated by maternal obesity, the contribution of emerging adipokines, including neuregulin-4 (NRG4) and isthmin-1 (ISM1), to the fetal adipokine profile remains incompletely understood. This study aimed to characterize alterations in the umbilical cord blood adipokine profile associated with maternal obesity and to evaluate their relationship with early neonatal outcomes.
Materials and methods: This prospective exploratory cohort study was conducted at Balıkesir University Faculty of Medicine Hospital, Balıkesir, Türkiye, and included 82 term singleton pregnancies delivered by cesarean section between March and May 2026. Participants were classified as obese (first-trimester BMI ≥30 kg/m², n=40) or non-obese (BMI <30 kg/m², n=42). Maternal demographic and biochemical characteristics, together with neonatal clinical outcomes, were recorded. Umbilical cord blood leptin, NRG4, and ISM1 concentrations were measured using enzyme-linked immunosorbent assay (ELISA). Between-group comparisons, partial correlation analysis, multivariate analysis of covariance (MANCOVA), and analysis of covariance (ANCOVA) were performed.
Results: Maternal glucose concentrations were significantly higher, whereas neonatal glucose concentrations were significantly lower, in the obese group (p = 0.009 and p < 0.001, respectively). Compared with the non-obese group, cord blood leptin and ISM1 concentrations were significantly increased, while NRG4 concentrations were significantly decreased (all p < 0.05). MANCOVA demonstrated a significant overall effect of maternal obesity on the adipokine profile, with leptin contributing most strongly to this association. Following adjustment, leptin remained independently associated with maternal obesity (ANCOVA: p < 0.001, η² = 0.28), whereas ISM1 and NRG4 were no longer independently significant. Partial correlation analysis demonstrated positive associations among the investigated adipokines, with the strongest correlation observed between ISM1 and NRG4 (r = 0.88, p < 0.001). No significant differences were observed between the groups regarding neonatal complications, Apgar scores, umbilical cord blood pH, lactate, bilirubin concentrations, or neonatal intensive care unit admission.
Conclusion: Maternal obesity was associated with an altered umbilical cord adipokine profile characterized by a robust increase in leptin together with coordinated alterations in emerging adipokines. Although these biochemical changes were not accompanied by differences in early neonatal outcomes, they may represent early metabolic adaptations to an obesogenic intrauterine environment. These findings support the potential role of cord blood adipokines as biomarkers of fetal metabolic programming and warrant confirmation in larger prospective longitudinal studies.
Related
- Maternal and Antenatal Complications in Pregnancies Complicated by Fetal Intra-Abdominal Umbilical Vein Varix
- Maternal and Neonatal Factors Impacting the Volume and Cellular Composition of Umbilical Cord Blood
- Respiratory Quotient During Pregnancy and the Influence of Macronutrient Intake, Energy Balance and Maternal Fat Mass: An Exploratory Study
- Exploratory Cross-Sectional Associations of Postpartum Maternal Body Mass Index and Infant Anthropometry with Human Milk Hormones and Cytokines
- Altered integrin αvβ3 and extracellular matrix-associated molecular profile in granulosa cells from women with polycystic ovary syndrome
BibTeX
@article{camili2026altered,
title = {{Altered umbilical cord adipokine profile associated with maternal obesity: an exploratory cohort study}},
author = {Figen Efe Camili and Ozlem Kemer Aycan and Merve Akis Yilmaz and Selim Afsar and Gurhan Guney and Mine İslimye Taskin},
journal = {Frontiers in Endocrinology},
year = {2026},
month = oct,
doi = {10.3389/fendo.2026.1936173},
url = {https://www.frontiersin.org/articles/10.3389/fendo.2026.1936173/full},
note = {CC BY 4.0},
}
RIS
TY - JOUR
TI - Altered umbilical cord adipokine profile associated with maternal obesity: an exploratory cohort study
AU - Figen Efe Camili
AU - Ozlem Kemer Aycan
AU - Merve Akis Yilmaz
AU - Selim Afsar
AU - Gurhan Guney
AU - Mine İslimye Taskin
PY - 2026
DA - 2026/10/26
JO - Frontiers in Endocrinology
DO - 10.3389/fendo.2026.1936173
UR - https://www.frontiersin.org/articles/10.3389/fendo.2026.1936173/full
AB - Background: Maternal obesity is associated with adverse pregnancy outcomes and may influence fetal metabolic programming through alterations in the intrauterine environment. While leptin has been extensively investigated in pregnancies complicated by maternal obesity, the contribution of emerging adipokines, including neuregulin-4 (NRG4) and isthmin-1 (ISM1), to the fetal adipokine profile remains incompletely understood. This study aimed to characterize alterations in the umbilical cord blood adipokine profile associated with maternal obesity and to evaluate their relationship with early neonatal outcomes. Materials and methods: This prospective exploratory cohort study was conducted at Balıkesir University Faculty of Medicine Hospital, Balıkesir, Türkiye, and included 82 term singleton pregnancies delivered by cesarean section between March and May 2026. Participants were classified as obese (first-trimester BMI ≥30 kg/m², n=40) or non-obese (BMI <30 kg/m², n=42). Maternal demographic and biochemical characteristics, together with neonatal clinical outcomes, were recorded. Umbilical cord blood leptin, NRG4, and ISM1 concentrations were measured using enzyme-linked immunosorbent assay (ELISA). Between-group comparisons, partial correlation analysis, multivariate analysis of covariance (MANCOVA), and analysis of covariance (ANCOVA) were performed. Results: Maternal glucose concentrations were significantly higher, whereas neonatal glucose concentrations were significantly lower, in the obese group (p = 0.009 and p < 0.001, respectively). Compared with the non-obese group, cord blood leptin and ISM1 concentrations were significantly increased, while NRG4 concentrations were significantly decreased (all p < 0.05). MANCOVA demonstrated a significant overall effect of maternal obesity on the adipokine profile, with leptin contributing most strongly to this association. Following adjustment, leptin remained independently associated with maternal obesity (ANCOVA: p < 0.001, η² = 0.28), whereas ISM1 and NRG4 were no longer independently significant. Partial correlation analysis demonstrated positive associations among the investigated adipokines, with the strongest correlation observed between ISM1 and NRG4 (r = 0.88, p < 0.001). No significant differences were observed between the groups regarding neonatal complications, Apgar scores, umbilical cord blood pH, lactate, bilirubin concentrations, or neonatal intensive care unit admission. Conclusion: Maternal obesity was associated with an altered umbilical cord adipokine profile characterized by a robust increase in leptin together with coordinated alterations in emerging adipokines. Although these biochemical changes were not accompanied by differences in early neonatal outcomes, they may represent early metabolic adaptations to an obesogenic intrauterine environment. These findings support the potential role of cord blood adipokines as biomarkers of fetal metabolic programming and warrant confirmation in larger prospective longitudinal studies.
SN - 1664-2392
ER -